[Co-sponsored by FRONTEO x Ballista] What are the traps and challenges that the manufacturing industry is likely to fall into in promoting DX? ~ Appropriate reform approach based on profit structure ~
In recent years, the manufacturing industry has been actively promoting DX, and many companies are working to introduce packaged solutions and IoT.On the other hand, however, the effect of the introduction was limited to a limited extent, and the reality is that only a small number of companies have achieved an increase in profits.One of the factors behind these problems is that the speed of DX and the issues faced by companies differ greatly depending on the production format and scale of the company. is required.
Therefore, this time, as a seminar co-sponsored by FRONTEO Co., Ltd. and Ballista Co., Ltd., we will explain the traps and challenges that the manufacturing industry is likely to fall into in promoting DX.After that, we will introduce a model case of transformation through the synergistic effect of the efforts of both companies, from understanding the profit structure to creating a monetization cycle.
◆ Title: [Co-sponsored by FRONTEO x Ballista] What are the traps and challenges that the manufacturing industry is likely to fall into in promoting DX?~ Appropriate reform approach based on profit structure ~
◆ Date: May 2023, 8 (Tuesday) 21: 16-00: 17
◆ Tools used: Zoom Webinars
Takato Nakagawa
After working for Deloitte Tohmatsu Consulting, Mizuho FG (BlueLab), Japan Post (JP Digital), and ExaWizards.
We have a lot of support achievements and implementation experience in the three axes of new business development, organizational reform, and marketing.
With CXO, he has extensive experience in formulating and executing transformation strategies, establishing companies, and launching new businesses.
Director / AI Solution Business Management and President's Office Manager
Mari Yamamoto
After joining an advertising agency, she was enrolled in a risk management company.Launch the mental health care business, execute business plans, product development, marketing, and sales strategies, and lead to the top market share in the industry. In 2014, she became a director of the company and was listed on the First Section of the Tokyo Stock Exchange in 2017.
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we will promote development in the digital health field such as diagnosis support and disease prediction using the AI engine "KIBIT".In the drug discovery field, we will greatly improve the efficiency of drug discovery research by fusing AI and drug discovery experts.・Develop business that supports acceleration and improvement of success rate, and challenge new areas in life science.
In the business intelligence business, he uses KIBIT to lead corporate DX promotion support.We will also develop AI-based solutions in the economic security field to support governments, public offices, and companies.
Articles in the same category
[Online seminar held on 5/30] Practical techniques for legal due diligence for M&A
[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis
[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -
[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
